Skip to search formSkip to main contentSkip to account menu

SNAR-A13 gene

Known as: SNAR-A13, small ILF3/NF90-associated RNA A13, snaR-A53139991 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by Bruton’s tyrosine kinase (BTK) mutation… 
2017
2017
SummaryThe goals of the present study were to define the anticancer activity of LFM-A13 (α-cyano-β-hydroxy-β-methyl-N-(2,5… 
2015
2015
Chronic rhinosinusitis (CRS) can be aggravated by viral upper respiratory infections. We aimed to investigate whether any… 
2014
2014
Aims This study is to investigate the mechanisms by which macrophage-activating lipopeptide-2 (MALP-2) induces heme oxygenase (HO… 
Highly Cited
2011
Highly Cited
2011
Heme oxygenase (HO)-1 is the inducible isoform of the rate-limiting enzyme of heme degradation and provides cytoprotection… 
2010
2010
During the preclinical drug discovery process it remains a challenge to enable early elimination of candidate molecules that may… 
Highly Cited
2007
Highly Cited
2007
2007
2007
  • F. Uckun
  • Cell cycle
  • 2007
  • Corpus ID: 11811642
LFM-A13 (α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide) has recently been identified as an inhibitor of Polo-like… 
2007
2007
The leflunomide (CAS 75706-12-6) metabolite (LFM) analog alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)-propenamide…